No. | Antigen | Overexpressed in HCC | Clinical trialsa | References |
---|---|---|---|---|
1 | hTERT | + | OC, BC, PC, melanoma, MM | |
2 | p53 | + (loss of function) | LC, BC, OC, melanoma, PC, HNSCC, CRC, CC | |
3 | Survivin | + | HCC, AML, ALL, OC, BC, PC, RCC, melanoma, MM, LC, EC, STS | |
4 | NY-ESO-1 | + | HCC, SS, MM, melanoma, OC, LC, oesophageal cancer; sarcoma, BC, bladder carcinoma | |
5 | CEA | + | CRC, LC, BC, GC, LM | |
6 | CCND1 | + | RCC | |
7 | c-MET | + | RCC, BC | |
8 | RGS5 | + | RCC | |
9 | MMP7 | + | RCC | |
10 | VEGFR | + | Melanoma, RC, RCC | [21] |
11 | AFP | + | HCC | |
12 | GPC3 | + | HCC | |
13 | HBV core antigen | + (when HBV+) | – | |
14 | HBV DNA polymerase | + (when HBV+) | – |  |